Dr. Sara Matar
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 13
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 266
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
OR license MD196355 -
Internal Medicine Physician
SC license 37269
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Asante Rogue Regional Medical Center Medford, OR
- Asante Three Rivers Medical Center Grants PAss, OR
- Sky Lakes Medical Center Klamath Falls, OR
- Asante Ashland Community Hospital Ashland, OR
- Curry General Hospital Gold Beach, OR
Medical groups
- Asante (149 clinicians)
- Asante Three Rivers Medical Center LLC (99 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 266
- Services billed
- 1,351
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 252 | 117 |
| Established patient office or other outpatient visit, 30-39 minutes | 219 | 153 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 66 | 43 |
| New patient office or other outpatient visit, 60-74 minutes | 49 | 49 |
| Established patient office or other outpatient visit, 20-29 minutes | 43 | 42 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 17 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in Medford, OR | 113 |
| Hydroxyurea Other prescribers in Medford, OR | 75 |
| Anastrozole Other prescribers in Medford, OR | 63 |
| Levothyroxine Sodium Other prescribers in Medford, OR | 51 |
| Eliquis (apixaban) Other prescribers in Medford, OR | 50 |
| Abiraterone Acetate | 48 |
| Tamoxifen Citrate Other prescribers in Medford, OR | 44 |
| Omeprazole Other prescribers in Medford, OR | 44 |
| Ondansetron Hcl Other prescribers in Medford, OR | 42 |
| Lorazepam Other prescribers in Medford, OR | 35 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 14 payments worth $660 in total to this clinician.
| Janssen Biotech, Inc. | $238 |
|---|---|
| GlaxoSmithKline, LLC. | $161 |
| Aveo Pharmaceuticals, Inc. | $120 |
| AbbVie Inc. | $42.90 |
| Genzyme Corporation | $35.59 |
| Kite Pharma, Inc. | $23.92 |
| Novartis Pharmaceuticals Corporation | $20.31 |
| Genentech USA, Inc. | $18.37 |
| Food and Beverage | $447 |
|---|---|
| Education | $213 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. Dec 11, 2025 | Education FOTIVDA · Oncology · in-kind | $99.99 |
| Janssen Biotech, Inc. Sep 5, 2025 | Education DARZALEX; TALVEY; TECVAYLI · Oncology · in-kind | $92.99 |
| Aveo Pharmaceuticals, Inc. Mar 21, 2025 | Education FOTIVDA · Oncology · in-kind | $20.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.